IMHO...you have your head screwed on backwards....BTW, both SAVA phase 3s have SPA , whereby one is fully enrolled and will be completed within 2024.... their path is clear, AVXL is NOT, other than speculative "intentions". Rett is the ONLY success story here, so the data release had better be unequivacable, since they have two identical protocols completed for that same indication.
Market Data 
Markets 
AI
